Skip to main content
. 2025 Nov 19;391:e086026. doi: 10.1136/bmj-2025-086026

Fig 3.

Fig 3

Pooled efficacy estimates of multiple comparisons in first line setting based on network meta-analysis. Data are pooled hazard ratios (95% credible intervals) for overall survival and progression-free survival. Bold data indicate statistical significance. BRAF=B-Raf proto-oncogene, serine/threonine kinase; Chemo=chemotherapy; DCT=doublet chemotherapy; EGFR=epidermal growth factor receptor; TCT=triplet chemotherapy; VEGF=vascular endothelial growth factor